These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 26944376

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Paget's disease and bisphosphonates.
    Rendina D, De Filippo G, Mossetti G.
    N Engl J Med; 2005 Dec 15; 353(24):2616-8; author reply 2616-8. PubMed ID: 16365936
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of Paget's disease--taming the wild osteoclast.
    Deftos LJ.
    N Engl J Med; 2005 Sep 01; 353(9):872-5. PubMed ID: 16135831
    [No Abstract] [Full Text] [Related]

  • 6. Persistent effect of zoledronic acid in Paget's disease.
    Tziomalos K, Florentin M, Krikis N, Perifanis V, Karagiannis A, Harsoulis F.
    Clin Exp Rheumatol; 2007 Sep 01; 25(3):464-6. PubMed ID: 17631747
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Zoledronate in the treatment of Paget's disease.
    Siris E.
    Br J Clin Pract Suppl; 1996 Sep 01; 87():19-20; discussion 22. PubMed ID: 8995014
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-Term Bone Scintigraphy Results After Intravenous Zoledronate in Paget's Disease of Bone.
    Reid IR, Maslowski K.
    Calcif Tissue Int; 2017 Jul 01; 101(1):43-49. PubMed ID: 28324123
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Primary hyperparathyroidism in a patient with Paget's bone disease].
    Guijarro de Armas MG, Pavón de Paz I, Zubieta Tabernero J, Civantos Modino S, Montaño Martínez JM, Díaz Guardiola P.
    Endocrinol Nutr; 2010 Apr 01; 57(4):170-3. PubMed ID: 20381437
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Strategies of treatment of Paget's disease with bisphosphonates.
    Papapoulos SE.
    Semin Arthritis Rheum; 1994 Feb 01; 23(4):265-6. PubMed ID: 8009248
    [No Abstract] [Full Text] [Related]

  • 17. [Intravenous bisphosphonates for bone Paget's disease: higher risk of adverse events].
    Grados D, Martínez-Morillo M, Holgado S, Erra A.
    Med Clin (Barc); 2014 May 20; 142(10):469-70. PubMed ID: 24120108
    [No Abstract] [Full Text] [Related]

  • 18. Diphosphonate treatment of Paget's disease.
    Finerman GA, Gonick HC, Smith RK, Mayfield JM.
    Clin Orthop Relat Res; 1976 Oct 20; (120):115-24. PubMed ID: 975646
    [Abstract] [Full Text] [Related]

  • 19. [Zoledronic acid efficacy in Paget's disease of bone: a three-year experience].
    Conesa Mateos A, Rotés Sala D, Almirall Bernabé M, Carbonell Abelló J.
    Med Clin (Barc); 2006 Oct 28; 127(16):635-6. PubMed ID: 17145033
    [No Abstract] [Full Text] [Related]

  • 20. [Biological and clinical effects of a new diphosphonate (chloro-4-phenyl) thiomethylene-diphosphonate in Paget's disease of bone].
    Lecart MP, Jeugmans-Huynen AM, Albert A, Denis D, Deroisy R, Fontaine MA, Collette J, Reginster JY, Franchimont P.
    Rev Med Liege; 1988 Dec 15; 43(24):799-806. PubMed ID: 3227219
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.